Australis operates and builds transformative, differentiated cannabis companies predominantly in the United States, a highly-regulated, fragmented, and rapidly expanding industry. Australis adheres to stringent evaluation and operating criteria focusing on high-quality opportunities while maintaining a steadfast commitment to governance and community. Australis’ Board and management team have material experience with, and knowledge of, the cannabis space in the U.S., extensive backgrounds in highly-regulated industries and regulatory compliance. Australis operating and portfolio assets include Rthm Technologies Inc., Body and Mind Inc., Quality Green Inc., Folium Biosciences, Mr. Natural Inc., and Green Therapeutics, LLC. Australis has also developed strategic partnerships with leading innovators such as Wagner Dimas.
North America’s emerging cannabis industry represents an unrivaled opportunity. In addition to the production and sale of cannabis products, this multibillion-dollar market presents a wide variety of complementary businesses in logistics, technology, product development, branding, research and development, and regulatory compliance.
AUSA adheres to stringent acquisition criteria and focuses on significant, high-quality opportunities with a steadfast commitment to governance and community. Members of the Board and management team have deep experience in highly regulated industries and knowledge of the U.S. cannabis industry. Together, they bring years of experience in regulatory compliance, public company governance, and operations.